The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms.
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms CONQUEST
- Sponsors ALTANA Pharma
- 04 May 2012 Additional trial location (Switzerland) added as reported by ClinicalTrials.gov.
- 04 May 2012 Actual patient number 40 added as reported by ClinicalTrials.gov.
- 04 May 2012 Planned end date changed from 20 Apr 2008 to 1 Nov 2008 as reported by ClinicalTrials.gov.